Become an “Ennov Insider” to gain unlimited access to our library of exclusive content
Register now to access case studies, whitepapers, videos and more!
Get complimentary access to this report:
"Gartner® Market Guide™ for Quality Management System Software 2022"
Ennov recognized by Gartner in 2020 Market Guide for Quality Management System Software
Ennov is Recognized in Gens & Associates 2020 World Class RIM Study
Ennov recognized in Gartner's 2021 Hype Cycle for Life Sciences Research & Development
An intuitive and unified content and information management platform to support and enrich the entire Life Sciences product life cycle
Download Septodont's Case Study
For more than 19 years, Ennov has been developing innovative, powerful and easy-to-use software for document and process management.
Using the knowledge and best practices gained from more than 150 Life Sciences customers and over 500 total customers, Ennov has designed and built solutions specifically for the health and life sciences sectors: Quality, Pharmacovigilance, Clinical Operations and Regulatory Affairs.
Ennov Compliance Platform
Unified Document Management, Business Process Management, Business Intelligence and Learning Management
Ennov solutions are built on our Unified Compliance Platform which is designed specifically for the management of regulated content and processes.
The Ennov platform is the technological foundation of our Regulatory (EDMS, Dossier Publishing, RIM, IDMP), Quality (EDMS, QMS) and Clinical (eTMF and CTMS) solutions.
Our platform approach provides significant advantages over other products on the market:
What's happening at Ennov
With the ever-changing landscape of RIM system compliance, it’s crucial to remain up to speed with the latest guidelines. In this article, discover the changes from Version 2.1 of the EMA IDMP Implementation Guide (IG) that was published June 30th,
Asphalion, a Scientific and Regulatory Affairs consultancy, hosts a weekly “RegTalk RIMS series”, one-to-one talks carried out by RIMS experts, aimed at informing about the latest news in the RIMS and Regulatory Affairs landscape. This RegTalks interview by Lidia Canovas,